Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2012
03/21/2012CN101663346B Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof
03/21/2012CN101606989B Novel preparation method of trollius chinensis granular preparation
03/21/2012CN101588792B Nanoemulsion
03/21/2012CN101406565B Pepper Babu plaster for rheumatism and method for producing the same
03/21/2012CN101340893B Intranasal administration of rapid acting insulin
03/21/2012CN101310717B preparation method of tanshinone IIA polylactic acid nano particles
03/21/2012CN101254270B External use traditional Chinese medicine preparation for curing gynecology inflammation and method of preparing the same
03/21/2012CN101249082B Preparation of acidum citricum tamoxifen polylactic acid-glycolic co-polymer microballoons
03/21/2012CN101208090B Stabilized composition
03/21/2012CN101184494B Method for preparing and separating phospholipids
03/21/2012CN101184473B Composition for use in the solubilisation of hydrophobic active agents
03/21/2012CN101181225B System for transferring nanometer polyalcohol micelle medicament and preparing method as well as application thereof
03/21/2012CN101164543B Acyl pseudopeptides bearing a functionalised auxiliary spacer
03/21/2012CN101130071B Vaccine
03/21/2012CN101032611B Antipruritic composite Chinese medicine and its preparing process
03/20/2012US8138314 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
03/20/2012US8138229 Compositions and methods of delivery of pharmacological agents
03/20/2012US8138155 Compounds for intracellular delivery of therapeutic moieties to nerve cells
03/20/2012US8138149 Nasal calcitonin formulations containing chlorobutanol
03/20/2012US8138144 Antimicrobial cationic peptides and formulations thereof
03/20/2012US8137711 Methods of treating neuropathy
03/20/2012US8137699 Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use
03/20/2012US8137690 Taste titration therapies
03/20/2012US8137689 Transplant/implant device and method for its production
03/20/2012US8137668 Methods and compositions for generating human monoclonal antibodies
03/20/2012CA2549840C Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
03/20/2012CA2524441C Treatment of lupus targeting the macrophages or the folate receptor
03/20/2012CA2510300C A process for the preparation of antioxidant conserve from indian curry leaves (murraya koenigii spreng.)
03/20/2012CA2498167C Water-soluble polymer alkanals
03/20/2012CA2493337C Polyamino acids functionalized by at least one hydrophobic group and the therapeutic applications thereof
03/20/2012CA2489526C Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof
03/20/2012CA2464478C A system and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form
03/20/2012CA2462227C Adhesive antineoplastic compositions
03/20/2012CA2435683C Hybridoma cell line g250 and its use for producing monoclonal antibodies
03/20/2012CA2424359C Implants with a phosphazene-containing coating
03/20/2012CA2410901C Methods and compounds for controlled release of recombinant parvovirus vectors
03/20/2012CA2406206C Improvements in or relating to formulations for use in inhaler devices
03/20/2012CA2405469C Integrin binding peptide derivatives
03/20/2012CA2402719C Method of preparing alkylated salicylamides via a dicarboxylate intermediate
03/20/2012CA2379564C Structural protein of adeno-associated virus with modified chromatographic properties, its production and use
03/20/2012CA2363067C Compounds and methods to inhibit or augment an inflammatory response
03/20/2012CA2351580C Stabilization of macrolides
03/15/2012WO2012033983A2 Candesartan pharmaceutical compositions
03/15/2012WO2012033938A2 Identification of pcna targeting compounds for cancer therapy and pcna function regulation
03/15/2012WO2012033911A2 Polyionic papilloma virus-like particle (vlp) vaccines
03/15/2012WO2012033538A1 Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
03/15/2012WO2012033478A1 An improved oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
03/15/2012WO2012033218A1 HYDROUS CRYSTALS OF 2-O-α-D-GLUCOSYL-L-ASCORBIC ACID, POWDER CONTAINING HYDROUS CRYSTALS OF 2-O-α-D-GLUCOSYL-L-ASCORBIC ACID, METHOD FOR PRODUCING THE HYDROUS CRYSTALS, METHOD FOR PRODUCING THE POWDER, USE OF THE HYDROUS CRYSTALS, AND USE OF THE POWDER
03/15/2012WO2012033196A1 Foamable aerosol composition
03/15/2012WO2012032497A1 Novel gene vaccination liposomes
03/15/2012WO2012032364A1 Stabilized solution of ortho-silicic acid based on salicylic acid as effective inhibitor of its polymerization, its preparation and use
03/15/2012WO2012032068A2 Compounds and methods
03/15/2012WO2012031934A1 Use of copolymers based on polymers containing amino groups as a matrix binder for the production of active ingredient-containing granules and administration forms
03/15/2012WO2012031609A1 Biodegradable, water soluble and ph responsive poly(organo)phosphazenes
03/15/2012WO2012031518A1 Localized pegylated modifications of exendin-4 analogs and use thereof
03/15/2012WO2012031457A1 A medicine delayed release vascular embolization gel used for treating tumor and preparation process thereof
03/15/2012WO2012010938A3 Pharmaceutical composition of cefditoren pivoxil
03/15/2012WO2011160062A3 Compositions and methods for treating inflammatory conditions
03/15/2012WO2011150212A3 Magnetic nanoparticles
03/15/2012WO2011146828A3 Cancer treatment
03/15/2012WO2011133635A3 Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same
03/15/2012WO2011126539A3 Extract of hamelia patens for the treatment of skin disorders
03/15/2012WO2011124570A3 Oral film formulation
03/15/2012WO2011104234A3 Multiplication of the efficacy of anti-infectious agents by a composition further comprising a dispersing agent together with a metal activating agent
03/15/2012WO2011101352A3 Test solvent for evaluating the compatibility of biologically active substances and graft copolymers
03/15/2012WO2011100234A3 Immunogenic hpv l2-containing vlps and related compositions, constructs, and therapeutic methods
03/15/2012WO2011089062A3 Pharmaceutical formulation for proteins
03/15/2012WO2011080209A3 Antibody formulation
03/15/2012WO2011077169A3 Pharmaceutical preparation comprising sufentanil
03/15/2012WO2011076368A3 Topical ophthalmic peptide formulation
03/15/2012WO2011073408A3 Pharmaceutical oral dosage form containing a synthetic oligosaccharide
03/15/2012WO2011069037A3 Stabilization and storage of biological pharmaceutical compositions
03/15/2012WO2002033044A9 Methods of high-throughput screening for internalizing antibodies
03/15/2012US20120065614 Polyionic transitional metal phosphorescent complex/polymer hybrid systems for bioimaging and sensing applications
03/15/2012US20120065429 Water-soluble polymer alkanals
03/15/2012US20120065368 Cyclodextrin-based polymers for therapeutics delivery
03/15/2012US20120065358 Biodegradable poly(beta-amino esters) and uses thereof
03/15/2012US20120065330 Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith
03/15/2012US20120065274 Azeotrope-like compositions comprising 1-chloro-3,3,3-trifluoropropene
03/15/2012US20120065238 Allantoin-containing skin cream
03/15/2012US20120065220 Tamper Resistant Dosage Form Comprising An Anionic Polymer
03/15/2012US20120065180 Androgen pharmaceutical composition and method for treating depression
03/15/2012US20120065138 Lipids, lipid complexes and use thereof
03/15/2012US20120065128 Crystalline forms of the di-sodium salt of n-(5-chlorosalicyloyl)-8-aminocaprylic acid
03/15/2012US20120065124 Cell-penetrating peptides
03/15/2012US20120064160 Fibrate-statin Combinations with Reduced Fed-fasted Effects
03/15/2012US20120064154 Solid drug for oral use
03/15/2012US20120064147 Agent for improving tissue penetration
03/15/2012US20120064146 Wound care device
03/15/2012US20120064145 Wound dressing
03/15/2012US20120064140 Composite nanogranules from polymer/inorganic nanoparticles, preparation method thereof and use of the same
03/15/2012US20120064135 Benzoyl Peroxide Composition, Methods for Making Same, and Pharmaceutical or Cosmetic Formulations Comprising Same, and Uses Thereof
03/15/2012US20120064133 Multiparticulate Controlled-Release Selective Serotonin Reuptake Inhibitor Formulations
03/15/2012US20120064129 Gastric retained gabapentin dosage form
03/15/2012US20120064098 Intracoronary Device And Method Of Use Thereof
03/15/2012US20120064086 High concentration antibody and protein formulations
03/15/2012US20120064061 Adhesive composition comprising tannin, poly(ethylene glycol), and water, lower alcohol or mixture thereof
03/15/2012US20120064022 Cyclosiloxane-substituted polysiloxane compounds, compositions containing the compounds and methods of use thereof
03/15/2012US20120064013 Foamable topical composition
03/15/2012US20120064011 Preparation for external application
1 ... 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 ... 1712